Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
AMPCO PITTSBURGH CORPAmpco-Pittsburgh Reports Mixed Q3 Results, Net Loss, and Improved Cash Position
EXAGEN INC.Exagen Inc. Reports Mixed Q3 Results with Revenue Growth and Improved Losses
Empery Digital, Inc.Volcon Reports Revenue Growth, Net Loss in Q3 2024, Cites Challenges with Manufacturing and Inventory
UNITED GUARDIAN INCUnited-Guardian Reports 17% Revenue Growth, Improved Profitability in Q3 2024
Great Elm Group, Inc.Great Elm Group Reports 21% Revenue Growth, Net Income Increase in Q3 2024
Plymouth Industrial REIT, Inc.Plymouth Industrial REIT Reports Mixed Q3 Results Amid Challenging Operating Environment
Data Call TechnologiesData Call Technologies Reports Decline in Revenues and Net Loss for Q3 2024
CIVISTA BANCSHARES, INC.Civista Bancshares Reports 19.5% Decrease in Net Income, 5.2% Increase in Total Assets in Q3 2024
ATOSSA THERAPEUTICS, INC.Atossa Therapeutics Reports Decrease in Cash and Cash Equivalents, Net Loss in Latest Quarter
CG Oncology, Inc.CG Oncology Reports Significant Financial Growth, Net Loss in Q3 2024
Mereo BioPharma Group plcMereo BioPharma Reports Net Loss of $15M, Increased Operating Expenses in Q3 2024
ARTELO BIOSCIENCES, INC.Artelo Biosciences Reports Q3 Financial Results, Improved Liquidity, and Reduced Operating Expenses
Indaptus Therapeutics, Inc.Indaptus Therapeutics Reports Decline in Cash and Cash Equivalents, Net Loss in Latest Quarter
Compass Therapeutics, Inc.Compass Therapeutics Reports Financial Results for Nine Months Ended September 30, 2024, with Increased Cash and Licensing Revenue
Advantage Solutions Inc.Advantage Solutions Reports Decline in Financial Performance for Q3 and Nine Months of 2024
Pyxis Oncology, Inc.Pyxis Oncology Reports Revenue Growth, Improved Losses, and Strategic Acquisitions in 9-Month Update
SUI Group Holdings Ltd.Mill City Ventures III, Ltd. Reports Mixed Q3 Results, Significant Improvement in Nine-Month Period
Alight, Inc. / DelawareAlight, Inc. Reports Slight Revenue Decline, Ongoing Profitability Challenges in Q3 2024
King Resources, Inc.OneSolution Technology Reports Improved Financials, Net Income Turnaround in Q2 2024
Shimmick CorpShimmick Corporation Reports Significant Financial Challenges, Net Losses in Latest Quarter
NV5 Global, Inc.NV5 Global Reports 5.6% Revenue Growth, Gross Profit Margin Increase in Q3 2024
BridgeBio Pharma, Inc.BridgeBio Pharma Reports Q3 2024 Financial Results, Significant Restructuring, and Milestone Payment Opportunity
Absci CorpAbsci Corporation Reports 129% Revenue Growth in Q3, Net Loss Widens
Roivant Sciences Ltd.Roivant Sciences Reports Revenue Growth, Increased Expenses, and Net Loss in Latest Quarter
Thoughtworks Holding, Inc.Thoughtworks Reports Decline in Revenue and Net Loss for Q3 and Nine Months of 2024